Pharma Focus Asia

Aitia Enters into Collaboration with Servier

Wednesday, May 17, 2023

Aitia announced a collaboration with Servier to create new Gemini Digital Twins to help in the fight against Pancreatic Cancer. This collaboration builds on an earlier collaboration in multiple myeloma that was announced in 2022.

Under the terms of the collaboration, Aitia and Servier will work together to focus on translational questions to discover, validate, and strive to develop novel drug targets and drug candidates in pancreatic cancer through utilization of Aitia’s Pancreatic Cancer Digital Twins and Servier’s pre-clinical assays, therapeutic creation platforms, and expertise. Servier will receive an exclusive option to research, develop, and commercialise products directed to several novel drug targets.

This expanded collaboration with Aitia will leverage discoveries from Gemini Digital Twins and harness the full potential of AI to make significant strides towards developing deeper biology of the disease and a better understanding of translational medicine questions such as biomarkers, patient stratifications, or the discovery of drug targets. This approach will generate novel mechanisms and hypotheses for potential new targeted therapies that will make a meaningful difference in the lives of patients with pancreatic cancer.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024